The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Early efficacy analysis of the AE37 vaccine in patients with HER2 low-expressing and triple-negative breast cancer.
Elizabeth Ann Mittendorf
Research Funding - Antigen Express
Sonia A. Perez
No relevant relationships to disclose
Diane F. Hale
No relevant relationships to disclose
Timothy J. Vreeland
No relevant relationships to disclose
Alan K. Sears
No relevant relationships to disclose
Guy T. Clifton
No relevant relationships to disclose
Alexandros Ardavanis
No relevant relationships to disclose
Nathan M. Shumway
No relevant relationships to disclose
James L. Murray
No relevant relationships to disclose
Sathibalan Ponniah
No relevant relationships to disclose
Michael Papamichail
No relevant relationships to disclose
George Earl Peoples
Consultant or Advisory Role - Antigen Express
Research Funding - Antigen Express